The relative contribution of insulin secretory capacity, insulin action, and incretins to metabolic control after islet transplantation in dogs
Autor: | Hhpj Lemkes, Ptr van Suylichem, Mpm van der Burg, Marijke Frölich, H. G. Gooszen, O. R. Guicherit |
---|---|
Rok vydání: | 1999 |
Předmět: |
medicine.medical_specialty
medicine.medical_treatment Glucagon-Like Peptides Islets of Langerhans Transplantation HEALTHY-SUBJECTS Incretin islet of Langerhans Gastric Inhibitory Polypeptide Biology Impaired glucose tolerance Islets of Langerhans Dogs Glucagon-Like Peptide 1 Internal medicine Insulin Secretion Drug Discovery medicine Animals Insulin Genetics (clinical) RELEASE function geography GLUCAGON-LIKE PEPTIDE-1 geography.geographical_feature_category Glucose Tolerance Test Glucagon medicine.disease Islet Glucagon-like peptide-1 incretin Peptide Fragments Insulin oscillation Transplantation Glucose Endocrinology Postprandial Molecular Medicine GLP-1 transplantation |
Zdroj: | Journal of Molecular Medicine, 77(1), 104-106. SPRINGER HEIDELBERG |
ISSN: | 1432-1440 0946-2716 |
DOI: | 10.1007/s001090050312 |
Popis: | Adequate metabolic control is central to the concept of islet transplantation, but has received limited attention. We studied metabolic control in 8 dogs at 6-9 months after intrasplenic autografting of approximately 25% of the normal mass islets--as compared to 30 controls. A similar posttransplant reduction to approximately 25% of the insulin secretory capacity as assessed by intravenous arginine stimulation during 35 mM glucose clamps, mirrored the reduction of the islet mass. Postprandially, in contrast, the insulin response had increased to 140% in the islet recipients--with a concomitant rise of glycemia to approximately 8.5 mM. Posttransplant, the insulin secretory capacity correlated both with the index of insulin action (which averaged 55% of the normal value) as assessed by euglycemic hyperinsulinemic clamps, and--inverse--with the postprandial glucose excursions. Because insulin action did not correlate with postprandial glucose, the insulin secretory capacity appears to be the primary determinant of the impaired glucose tolerance. Marked postprandial hyperglucagonemia, and a virtually absent pancreatic polypeptide response in the grafted animals, may also have contributed to the impaired glucose tolerance. Posttransplant, infusion of a physiological dose of the gut hormone glucagon-like peptide-1 during 8.5 mM glucose clamps--mimicking the postprandial glycemia--potentiated glucose-stimulated insulin 175%. Thus, after transplantation of a suboptimal islet mass, postprandial glucose excursions are restrained by hyperglycemic potentiation of the entero-insular axis, which may account for the difference in the insulin response to the intravenous and oral challenges. Because, the insulin secretory capacity reflects the islet mass and appears to be the major determinant of glucoregulation, transplantation of a larger islet mass may allow near-normal glycemic control. |
Databáze: | OpenAIRE |
Externí odkaz: |